Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Nov;60(5):1116–1128. doi: 10.1172/JCI108863

In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

J M Vierling, D L Nelson, W Strober, D M Bundy, E A Jones
PMCID: PMC372464  PMID: 332716

Abstract

The in vitro cytotoxic function and target cell specificity of peripheral blood lymphocytes from selected patients with primary biliary cirrhosis and hepatitis B surface antigen-negative chronic hepatitis were investigated using 51Cr-labeled human Chang and EL-4 mouse sarcoma cell targets in assays of spontaneous cell-mediated cytotoxicity (SCMC) and mitogen-induced cellular cytotoxicity (MICC). In addition, antibody-dependent cellular cytotoxicity (ADCC) against Chang cells was assessed. At an effector-to-target cell ration of 100:1, the mean SCMC against Chang cells was much less in patients with primary biliary cirrhosis than that in either the controls (P less than 0.001) or the patients with chronic hepatitis (P less than 0.005) whereas the value for patients with chronic hepatitis did not differ significantly from that of the controls. The mean SCMC against EL-4 mouse sarcoma cells was also less in patients with primary biliary cirrhosis than in controls (P less than 0.005) whereas the value for chronic hepatitis was not significantly different from that of the controls or patients with primary biliary cirrhosis. In contrast, MICC against both targets and ADCC against Chang cells were similar for each group. Comparison of SCMC and MICC against both target cells, measured simultaneously, showed similar cytotoxic potenital against both target cells for each group. Effector cells capable of mediating cytotoxicity in each assay were defined by testing the cytotoxic function of lymphocyte subpopulations isolated from two representative patients with each disease using techniques of immunoabsorbent affinity chromatography and Fc receptor binding to antigen-antibody complexes. In both primary biliary cirrhosis and chronic hepatitis SCMC and ADCC were mediated by a subpopulation of lymphocytes which lack surface immunoglobulin (sIg-) and bear Fc receptors (Fc+). In contrast, MICC was mediated by sIg- cells which lack Fc receptors. Lymphocytes bearing sIg- were not cytotoxic in any assay. These results establish a difference in cytotoxic function in primary biliary cirrhosis and chronic hepatitis by defining the presence of a defect in spontaneous cytotoxic function of sIg-, Fc+ lymphocytes against Chang cells in primary biliary cirrhosis.

Full text

PDF
1116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander E., Henkart P. The adherence of human Fc receptor-bearing lymphocytes to antigen-antibody complexes. II. Morphologic alterations induced by the substrate. J Exp Med. 1976 Feb 1;143(2):329–347. doi: 10.1084/jem.143.2.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOYUM A. SEPARATION OF WHITE BLOOD CELLS. Nature. 1964 Nov 21;204:793–794. doi: 10.1038/204793a0. [DOI] [PubMed] [Google Scholar]
  3. Bacon P. A., Berry H., Bown R. Cell-mediated immune reactivity in liver disease. Gut. 1972 Jun;13(6):427–429. doi: 10.1136/gut.13.6.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bianchi P., Porro C. B., Coltorti M., Dardanoni L., Del Vecchio Blanco C., Fagiolo U., Farini R., Menozzi I., Naccarato R., Pagliaro L. Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology. 1972 Sep;63(3):482–485. [PubMed] [Google Scholar]
  5. Boyer J. L. Chronic hepatitis--a perspective on classification and determinants of prognosis. Gastroenterology. 1976 Jun;70(6):1161–1171. [PubMed] [Google Scholar]
  6. Bulkley B. H., Goldfinger S. E., Heizer W. D., Isselbacher K. J., Shulman N. R. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970 Dec 26;2(7687):1323–1326. doi: 10.1016/s0140-6736(70)92356-1. [DOI] [PubMed] [Google Scholar]
  7. Chess L., MacDermott R. P., Schlossman S. F. Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol. 1974 Oct;113(4):1113–1121. [PubMed] [Google Scholar]
  8. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  9. Dudley F. J., Fox R. A., Sherlock S. Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet. 1972 Apr 1;1(7753):723–726. doi: 10.1016/s0140-6736(72)90234-6. [DOI] [PubMed] [Google Scholar]
  10. Dudley F. J., O'Shea M. J., Ajdukiewicz A., Sherlock S. Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease. Gut. 1973 May;14(5):360–364. doi: 10.1136/gut.14.5.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dudley F. J., Scheuer P. J., Sherlock S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet. 1972 Dec 30;2(7792):1388–1393. doi: 10.1016/s0140-6736(72)92963-7. [DOI] [PubMed] [Google Scholar]
  12. Fauci A. S., Dale D. C. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest. 1975 Jan;55(1):22–32. doi: 10.1172/JCI107914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Finlayson N. D., Krohn K., Anderson K. E., Jokelainen P. T., Prince A. M. Interrelations of hepatitis B antigen and autoantibodies in chronic idiopathic liver disease. Gastroenterology. 1972 Oct;63(4):646–652. [PubMed] [Google Scholar]
  14. Geubel A. P., Keller R. H., Summerskill W. H., Dickson E. R., Tomasi T. B., Shorter R. G. Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology. 1976 Sep;71(3):450–456. [PubMed] [Google Scholar]
  15. Gitnick G. L., Gleich G. J., Schoenfield L. J., Baggenstoss A. H., Sutnick A. I., Blumberg B. S., London W. T., Summerskill W. H. Australia antigen in chronic active liver disease with cirrhosis. Lancet. 1969 Aug 9;2(7615):285–288. doi: 10.1016/s0140-6736(69)90052-x. [DOI] [PubMed] [Google Scholar]
  16. Holm G., Perlmann P. Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology. 1967 May;12(5):525–536. [PMC free article] [PubMed] [Google Scholar]
  17. Hoofnagle J. H., Gerety R. J., Barker L. F. Antibody to hepatitis-B-virus core in man. Lancet. 1973 Oct 20;2(7834):869–873. doi: 10.1016/s0140-6736(73)92004-7. [DOI] [PubMed] [Google Scholar]
  18. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lundgren G., Möller G. Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol. 1969 Apr;4(4):435–452. [PMC free article] [PubMed] [Google Scholar]
  20. MacSween R. N., Galbraith I., Thomas M. A., Watkinson G., Ludlam G. B. Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clin Exp Immunol. 1973 Sep;15(1):35–42. [PMC free article] [PubMed] [Google Scholar]
  21. Maddrey W. C., Saito S., Shulman N. R., Klatskin G. Coincidental Australia antigenemia in primary biliary cirrhosis. Ann Intern Med. 1972 May;76(5):705–709. doi: 10.7326/0003-4819-76-5-705. [DOI] [PubMed] [Google Scholar]
  22. Meyer zum Büschenfelde, Miescher P. A. Liver specific antigens. Purification and characterization. Clin Exp Immunol. 1972 Jan;10(1):89–102. [PMC free article] [PubMed] [Google Scholar]
  23. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  24. Nelson D. L., Bundy B. M., Blaese R. M., Strober W. Cytotoxic effector cell function in organized gut-associated lymphoid tissue (GALT). Cell Immunol. 1976 Mar 1;22(1):165–175. doi: 10.1016/0008-8749(76)90017-4. [DOI] [PubMed] [Google Scholar]
  25. Nelson D. L., Bundy B. M., Pitchon H. E., Blaese R. M., Strober W. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1976 Nov;117(5 Pt 1):1472–1481. [PubMed] [Google Scholar]
  26. Paronetto F., Vernace S. Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture. Clin Exp Immunol. 1975 Jan;19(1):99–104. [PMC free article] [PubMed] [Google Scholar]
  27. Perlmann P., Perlmann H., Holm G. Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science. 1968 Apr 19;160(3825):306–309. doi: 10.1126/science.160.3825.306. [DOI] [PubMed] [Google Scholar]
  28. Peter H. H., Pavie-Fischer J., Fridman W. H., Aubert C., Cesarini J. P., Roubin R., Kourilsky F. M. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). J Immunol. 1975 Aug;115(2):539–548. [PubMed] [Google Scholar]
  29. Reed W. D., Eddleston A. L., Williams R. Immunopathology of viral hepatitis in man. Prog Med Virol. 1974;17(0):38–76. [PubMed] [Google Scholar]
  30. Reed W. D., Stern R. B., Eddleston A. L., Williams R., Zuckerman A. J., Bowes A., Earl P. M. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet. 1973 Sep 29;2(7831):690–694. doi: 10.1016/s0140-6736(73)92534-8. [DOI] [PubMed] [Google Scholar]
  31. Sandilands G., Gray K., Cooney A., Froebel K., Anderson J. R. Human lymphocyte sub-populations and K cells. Int Arch Allergy Appl Immunol. 1976;50(4):416–426. doi: 10.1159/000231531. [DOI] [PubMed] [Google Scholar]
  32. Santoli D., Trinchieri G., Zmijewski C. M., Koprowski H. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol. 1976 Sep;117(3):765–770. [PubMed] [Google Scholar]
  33. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med. 1967 Dec;60(12):1257–1260. doi: 10.1177/003591576706001205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Sherlock S., Fox R. A., James D. G., Scheuer P. J., Sharma O. Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet. 1969 May 10;1(7602):959–962. doi: 10.1016/s0140-6736(69)91860-1. [DOI] [PubMed] [Google Scholar]
  35. Smith M. G., Golding P. L., Eddleston A. L., Mitchell C. G., Kemp A., Williams R. Cell-mediated immune responses in chronic liver diseases. Br Med J. 1972 Feb 26;1(5799):527–530. doi: 10.1136/bmj.1.5799.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sondel P. M., Chess L., MacDermott R. P., Schlossman S. F. Immunologic functions of isolated human lymphocyte subpopulations. III. Specific allogeneic lympholysis mediated by human T cells alone. J Immunol. 1975 Mar;114(3):982–987. [PubMed] [Google Scholar]
  37. Stobo J. D., Tomasi T. B., Huizenga K. A., Spencer R. J., Shorter R. G. In vitro studies of inflammatory bowel disease. Surface receptors of the mononuclear cell required to lyse allogeneic colonic epithelial cells. Gastroenterology. 1976 Feb;70(2):171–176. [PubMed] [Google Scholar]
  38. Thomson A. D., Cochrane M. A., McFarlane I. G., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature. 1974 Dec 20;252(5485):721–722. doi: 10.1038/252721a0. [DOI] [PubMed] [Google Scholar]
  39. Wands J. R., Perrotto J. L., Alpert E., Isselbacher K. J. Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest. 1975 May;55(5):921–929. doi: 10.1172/JCI108021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wands K. R., Isselbacher K. J. Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1301–1303. doi: 10.1073/pnas.72.4.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wisloff F., Froland S. S., Michaelsen T. E. Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes. Int Arch Allergy Appl Immunol. 1974;47(1):139–154. doi: 10.1159/000231208. [DOI] [PubMed] [Google Scholar]
  42. Wright R., McCollum R. W., Klatskin G. Australia antigen in acute and chronic liver disease. Lancet. 1969 Jul 19;2(7612):117–121. doi: 10.1016/s0140-6736(69)92437-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES